Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: A Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy

Published 2010 View Full Article

Authors

Keywords

Journal

THROMBOSIS RESEARCH

Volume 127, Issue 2, Pages 91-99

Publisher

Elsevier BV

Online

2010-12-20

DOI

10.1016/j.thromres.2010.11.012

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

THROMBOSIS RESEARCH

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find the ideal target journal for your manuscript

Ask a Question. Answer a Question.